A vomiting-free ward protocol significantly reduced the effects of nausea and vomiting on QOL, anxiety, and depression, in patients with gynecologic cancers receiving chemotherapy.

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting ...

Data were presented by Bobby May Jr, MD, and colleagues at the Society of Gynecologic Oncology 2025 Winter Meeting. 1 Results indicated that among patients in the FRα cohort (n = 80), 82.5% of patient ...

Dr. Mirza also currently serves as the medical director of the Nordic Society of Gynecologic Oncology Clinical Trial Unit. His expertise is in both medical and radiological oncology, with a primary ...

“ADCs are a hot topic for a reason across solid and hematologic tumors: They’re working,” Moore said in a presentation at the 2025 Society of Gynecologic Oncology Winter Meeting in Whistler, British ...

University of Kentucky Markey Cancer Center researchers presented ... approach to ovarian cancer maintenance therapy at the Society of Gynecologic Oncology annual meeting in Seattle (SGO 2025).

Detailed price information for Acrivon Therapeutics Inc (ACRV-Q) from The Globe and Mail including charting and trades.

Zentalis ® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin ...

Objectives: The objective of this study was to evaluate global longitudinal publication trends in oncology in the Cochrane Database of Systematic Reviews (CDSR) from 2001-2020. Design: Retrospective ...

The Johns Hopkins F.J. Montz Fellowship in Gynecologic Oncology is a three-year program with one to two fellowship positions available each year. Our goal is to train world-class abdominal-pelvic ...